FranckeD. E.WhitneyH. A. K.Jr. (Eds.): Perspectives in Clinical Pharmacy, Drug Intelligence Publications, the Hamilton Press, Hamilton, Ill., 1972.
2.
SkinnerW. J., Director Project: Clinical Pharmacy Education and Training Programs, A Special Report, American Association of Colleges of Pharmacy, Silver Spring, Md., 1972.
3.
RodowskasC. A.: Pharmacy School Faculty Changes Reflect Clinical Trend, News release, American Association of Colleges of Pharmacy, Silver Spring, Md., 1971.
4.
GeeJ. S.: Clinical Pharmacy Program at San Francisco VA Hospital, Unpublished document.
5.
McCarronM. M.: Senior Clinical Pharmacy Clerkship, 1970–1971, University of Southern California School of Pharmacy. Mimeographed documents.
6.
DenoR. A. (Ed.): Proceedings of the Conference on Health Education, Pharmacy-Medicine-Nursing, College of Pharmacy, University of Michigan, Ann Arbor, 1967.
7.
BrodieD. C. (Ed.): Challenge to Pharmacy in the 70's, Conference Highlights, University of California, San Francisco, 1970.
8.
Proceedings of the ASHP-AACP Invitational Workshop on Clinical Pharmaceutical Practice and Education, Am. J. Hosp. Pharm.25: 842, 1971.
9.
British Pharmaceutical Society: Report of Working Party on Applied Pharmacology, Pharm. J.207: 517, 1971.
10.
BrownJ. H. U.: Clinical Pharmacology: The Neglected Science. J. Med. Ed.44: 961, 1969.
11.
World Health Organization: Clinical Pharmacology: Scope, Organization and Training, Technical Report Series 446, Geneva, 1970.
12.
LasagnaL.: The Pharmaceutical Revolution: Its Impact on Science and Society, Science166: 1233, 1969.
13.
OsierW.: Teaching and Thinking, in Aequanimitas With Other Addresses to Medical Students, Nurses and Practitioners of Medicine, The Blakiston Company, Philadelphia, p. 121, 1951.
14.
CluffL. H.: Problems with Drugs, A Perspective, Proceedings. Conference on Continuing Education for Physicians in the Use of Drugs. Drug Research Board, National Academy of Sciences—National Research Council, Washington, D.C., p. 9, Feb. 5, 1969.
15.
DowlingH. F.: How Doctors Use Drugs, Proc. Conference on Continuing Education for Physicians in the Use of Drugs. Drug Research Board, National Academy of Sciences—National Research Council, Washington, D.C., p. 12, Feb. 5, 1969.
16.
SchmidtC. F.: Personal Summary of Conference Finding, Proc. Conference on Continuing Education for Physicians in the Use of Drugs. Drug Research Board, National Academy of Sciences—National Research Council, Washington, D.C., p. 24, Feb. 5, 1969.
17.
StandaertF. G.: The Ideal Compendium: What Is It?—From the Standpoint of the Medical Educator, Drug Inf. Bull.4: 204, 1970.
18.
HirschmanJ. L.TroutmanW. G.: The DIAS Rounds, Drug Information Analysis Service, Drug Intell. Clin. Pharm.6: 21, 1972.
19.
LasagnaL.: Clinical Pharmacology: Present Status and Future Development, Science152: 388, 1966.
20.
Drug Research Board, Division of Medical Sciences, National Research Council: Report of the Conference on Clinical Pharmacology, December 3–4, 1970. National Academy of Sciences, Washington, D.C., 1971.
21.
PellegrinoE.: Relationship of Medical and Pharmacy Education, Proceedings, Conference on Challenge to Pharmacy in the 70's. University of California College of Pharmacy, 1970.
22.
Drug Research Board, Division of Medical Sciences, National Research Council: Report of the International Conference on Adverse Reactions Reporting Systems, National Academy of Sciences, Washington, D.C., 1971.
23.
RoyallB. W.: International Aspects of Drug Monitoring—Role of the World Health Organization, WHO Chron.25: 445, 1971.
24.
Report of the Symposium on Drug Consumption in Europe, (document EURO-3102), WHO Chron.25: 458, 1971.
25.
BrodieD. C.: Drug Utilization and Drug Utilization Review and Control, Department of Health, Education and Welfare Publication HSM 72–3002, Rockville, Md.
26.
MarondeR. F.LeeP. V.McCarronM. M.SeibertS.: A Study of Prescribing Habits, Med. Care9: 383, 1971.
27.
World Health Organization: Principles for Preclinical Testing of Drug Safety, Technical Report Series 341, Geneva, p. 22, 1966.
28.
Task Force on Prescription Drugs: Final Report, U.S. Department of Health, Education and Welfare, Washington, D.C., pp. 21, 31, 36, 1969.
29.
MoertelC. G.AhmannD. L.TaylorW. F.SchwartauN.: A Comparative Evaluation of Marketed Analgesic Drugs, N. Engl. J. Med.286: 813, 1972.